Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
120mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
240 mg glatiramer acetate2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---2件: 2, 13 💬
3Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer (Teva-glatiramer Acetate)		2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 13 💬
4Experimental Glatiramer Acetate2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
5GLATIRAMER ACETATE2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---3件: 13, 96, 156 💬
6Glatiramer Acetate (Copaxone®)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---2件: 13, 156 💬
7Glatiramer Acetate (DB)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
8Glatiramer Acetate (GA)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
9Glatiramer Acetate (GA) 40 mg2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
10Glatiramer Acetate (GTR)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
11Glatiramer Acetate (OL)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
12Glatiramer acetate 150mg enteric coated tablets2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
13Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
14Glatiramer acetate 20 mg2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
15Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer (Teva-glatiramer Acetate),
Mitoxantrone		1件: Mitoxantrone 💬 2件: TOP2A,
TOP2B 💬 		1件: Platinum drug resistance 💬1件: 13 💬
16Glatiramer Acetate 20 mg/0.5 mL2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
17Glatiramer acetate 40 mg2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
18Glatiramer Acetate [GA]2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
19Glatiramer acetate injection with oral cetirizine hydrochloride3件: Acetate,
Cetirizine,
Glatiramer (Teva-glatiramer Acetate)		1件: Cetirizine 💬 1件: HRH1 💬 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
20Glatiramer acetate with minocycline3件: Acetate,
Glatiramer (Teva-glatiramer Acetate),
Minocycline		1件: Minocycline 💬 --1件: 13 💬
21Glatiramer acetate, (Copaxone®)2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
22Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b2件: Acetate,
Glatiramer (Teva-glatiramer Acetate)		---1件: 13 💬
23Glatiramer Acetate, N-Acetylcysteine3件: Acetate,
Acetylcysteine,
Glatiramer (Teva-glatiramer Acetate)		1件: Acetylcysteine 💬 --1件: 13 💬
24Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer (Teva-glatiramer Acetate),
Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
25Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer (Teva-glatiramer Acetate),
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬 		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬 		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬